Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, AstraZeneca Pharma India has informed that it enclosed the disclosure of Related Party Transactions for half year ended September 30, 2021.
The above information is a part of company’s filings submitted to BSE.